"Designing Growth Strategies is in our DNA"

Hematology Analyzers and Reagents Market Size, Share and Global Trend By Product Type (Instruments, Reagents), By End User (Diagnostic laboratories, Hospitals & Clinics, Research institutes, Others), and Geography Forecast till 2021-2028

Region : | Report ID: FBI101028 | Status : Ongoing

 

KEY MARKET INSIGHTS

In February 2019, ERBA Diagnostics launched the company’s newly developed hematology analyzers in MEDLAB 2019. Hematology analyzer and reagents are used for blood tests that provide qualitative and quantitative data regarding white blood count, red blood count, and coagulation test.

The recent product launches by major players are projected to fuel the global hematology analyzer and reagents market growth during the forecast period. Additionally, the increasing awareness regarding chronic diseases and the importance of maintaining good health among patient population is estimated to boost the global hematology analyzers and reagent market potential.

To gain extensive insights into the market, Request for Customization


The global hematology analyzers and reagents market growth is being driven by many factors such as recent technological advancement in the field and the current product launches. For instance, in May 2018, Beckman Coulter announced the launch of DxH 900 hematology analyzer and is available in Europe, United States, New Zealand, and Australia.

Combined with this, the rise in the prevalence of diseases like sickle cell anemia, blood cell cancer, HIV, among others, are anticipated to drive the global hematology analyzers and reagents market positively. According to the American Society of Hematology, 3 million people in America suffer from anemia.


Slow adoption of automated hematology analyzers in emerging countries and high cost of equipment are considerd to restrain the growth of global hematology analyzers and reagents market.


Key Players Covered


Key players operating in the global hematology analyzers and reagents market are ERBA Diagnostics, Siemens AG, Beckman Coulter, Sysmex Corporation, Bio-Rad Laboratories, Abbott Laboratories, Ortho Clinical Diagnostics Hoffmann-La Roche Ltd and other players.


SEGMENTATION 






















SEGMENTATION



 DETAILS



By Product Type



· Instruments


      - Semi-automated analyzers


      - Fully automated analyzers


      - Point-of-care testing


· Reagents



By End User



· Diagnostic laboratories


· Hospitals & Clinics


· Research institutes


· Others



By Geography



· North America (USA and Canada)


· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)


· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)


· Latin America (Brazil, Mexico and Rest of Latin America)


· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



 


At present, among product types, the instruments are likely to hold the major share of the global hematology analyzers and reagents market due to the high cost associated with the analyzers.


Key Insights



  • New product launches

  • Overview of regulatory scenario for key countries

  • Key mergers and acquisitions

  • Prevalence of major hematological disorder – key countries


Regional Analysis


The global hematology analyzers and reagents market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to dominate the global hematology analyzer and reagents industry owing to the robust presence of major players and increasing investment to develop novel and higher accurate result generating medical devices. Europe is projected to follow the lead in the global hematology analyzers and reagents market due to the increase in the number of diagnostic clinics and raising awareness of hematological disorders. The global hematology analyzers and reagent market opportunity is projected to be the highest in the untapped markets of Asia Pacific, Latin America and the Middle East and Africa owing to the increasing prevalence of hematological disorders among the patient population.


Hematology Analyzers and Reagents Industry Developments




  • In November 2018, PixCell Medical Technologies Ltd. received 510(k) approval from the U.S Food and Drug Administration approval for the company’s HemoScreen hematology analyser for point-of-care use.
  • In March 2018, U.S FDA cleared Roche's cobas m 511 hematology analyzer.
  • In May 2019, Beckman Coulter was issued a Class 1 device recall for DxH 800, DxH 600, and DxH 900 hematology analyzers from the U.S FDA owing to inaccurate results.

Hematology Analyzers and Reagents Market  Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • $4850
    $6850
    $8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Fresenius
Siemens Healthineers
Jubilant
uniliver
Roche

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X